Emily Postan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emily Postan has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Termine
University of Applied Sciences and Arts of Southern Switzerland, Dalle Molle Institute for Artificial Intelligence
2 shared publications - Alessandro Facchini
SUPSI, Dalle Molle Institute for Artificial Intelligence Research (IDSIA), Lugano, Switzerland
2 shared publications - Andrea Ferrario
University of Zurich, Zurich, Switzerland, SUPSI - University of Applied Sciences Southern Switzerland, Lugano, Switzerland, and ETH Zurich, Zurich, Switzerland
2 shared publications - Bogdan Kulynych
Lausanne University Hospital (CHUV), Lausanne, Switzerland
2 shared publications - Derya Sahin
Development Economics (DEC), World Bank Group, Washington, DC, United States
2 shared publications - Elise E. Racine
Nuffield Department of Population Health, Ethox Centre, University of Oxford, Oxford, UK
2 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Springer Nature in Philosophy & Technology
- Vol. 39 (3)
Uncanny Human Kinds: the Problematic Social Life of Deep Learning-Generated Health Categories
There is marked enthusiasm about the potential for deep learning (DL) systems to generate new data-driven diagnostic, predictive, and prognostic health categories that could support more effective, precisely targeted healthcare. This article argues that, in order to determine whether these novel categories would be ethically desirable ones, we cannot look only to their clinical utility, or to the threats posed to this by widely recognised problems of algorithmic error, bias, and opacity. This is because health categories do not only classify disease and inform care. They also classify people. And they do so for ethically impactful purposes that extend far beyond the clinic. In light of this, and to address the central question of whether novel DL-generated health categories would constitute good or supportive ways of classifying people, this article appeals to the concept of human kinds. This framing serves to highlight how diagnostic and predictive health categories can shape the identities and relationships of the people classified in ethically significant ways. It is argued here that DL-generated health categories could occupy the roles of human kinds. However, they are likely to exhibit particular qualities that distinguish them from familiar human kinds that have originated in human practices. And these qualities could result in marked disjunctions between, on one hand, the meanings and membership of these kinds, and on the other hand, members’ characteristics and lived contexts, resulting in uncannily abstracted kinds. As a result of this uncanniness, kinds originating in DL-generated health categories could significantly undermine the wellbeing and interests of their members in a range of important ways. For this reason, when assessing the ethical desirability of using DL to generate data-driven diagnoses and health predictions, it is necessary to assess not only the clinical value of these diagnoses and predictions, but also the risks of seeding uncanny human kinds.
- 26 June 2026
- Published by Springer Nature in Philosophy & Technology
- Vol. 39 (3)
Open AccessUncanny Human Kinds: the Problematic Social Life of Deep Learning-Generated Health Categories
There is marked enthusiasm about the potential for deep learning (DL) systems to generate new data-driven diagnostic, predictive, and prognostic health categories that could support more effective, precisely targeted healthcare. This article argues that, in order to determine whether these novel categories would be ethically desirable ones, we cannot look only to their clinical utility, or to the threats posed to this by widely recognised problems of algorithmic error, bias, and opacity. This is because health categories do not only classify disease and inform care. They also classify people. And they do so for ethically impactful purposes that extend far beyond the clinic. In light of this, and to address the central question of whether novel DL-generated health categories would constitute good or supportive ways of classifying people, this article appeals to the concept of human kinds. This framing serves to highlight how diagnostic and predictive health categories can shape the identities and relationships of the people classified in ethically significant ways. It is argued here that DL-generated health categories could occupy the roles of human kinds. However, they are likely to exhibit particular qualities that distinguish them from familiar human kinds that have originated in human practices. And these qualities could result in marked disjunctions between, on one hand, the meanings and membership of these kinds, and on the other hand, members’ characteristics and lived contexts, resulting in uncannily abstracted kinds. As a result of this uncanniness, kinds originating in DL-generated health categories could significantly undermine the wellbeing and interests of their members in a range of important ways. For this reason, when assessing the ethical desirability of using DL to generate data-driven diagnoses and health predictions, it is necessary to assess not only the clinical value of these diagnoses and predictions, but also the risks of seeding uncanny human kinds.
- Top Cited PapersOpen Access
- 19 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e56306
Finding Consensus on Trust in AI in Health Care: Recommendations From a Panel of International Experts
Background: The integration of artificial intelligence (AI) into health care has become a crucial element in the digital transformation of health systems worldwide. Despite the potential benefits across diverse medical domains, a significant barrier to the successful adoption of AI systems in health care applications remains the prevailing low user trust in these technologies. Crucially, this challenge is exacerbated by the lack of consensus among experts from different disciplines on the definition of trust in AI within the health care sector. Objective: We aimed to provide the first consensus-based analysis of trust in AI in health care based on an interdisciplinary panel of experts from different domains. Our findings can be used to address the problem of defining trust in AI in health care applications, fostering the discussion of concrete real-world health care scenarios in which humans interact with AI systems explicitly. Methods: We used a combination of framework analysis and a 3-step consensus process involving 18 international experts from the fields of computer science, medicine, philosophy of technology, ethics, and social sciences. Our process consisted of a synchronous phase during an expert workshop where we discussed the notion of trust in AI in health care applications, defined an initial framework of important elements of trust to guide our analysis, and agreed on 5 case studies. This was followed by a 2-step iterative, asynchronous process in which the authors further developed, discussed, and refined notions of trust with respect to these specific cases. Results: Our consensus process identified key contextual factors of trust, namely, an AI system’s environment, the actors involved, and framing factors, and analyzed causes and effects of trust in AI in health care. Our findings revealed that certain factors were applicable across all discussed cases yet also pointed to the need for a fine-grained, multidisciplinary analysis bridging human-centered and technology-centered approaches. While regulatory boundaries and technological design features are critical to successful AI implementation in health care, ultimately, communication and positive lived experiences with AI systems will be at the forefront of user trust. Our expert consensus allowed us to formulate concrete recommendations for future research on trust in AI in health care applications. Conclusions: This paper advocates for a more refined and nuanced conceptual understanding of trust in the context of AI in health care. By synthesizing insights into commonalities and differences among specific case studies, this paper establishes a foundational basis for future debates and discussions on trusting AI in health care.
- 19 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e56306
Top Cited PapersOpen AccessFinding Consensus on Trust in AI in Health Care: Recommendations From a Panel of International Experts
Background: The integration of artificial intelligence (AI) into health care has become a crucial element in the digital transformation of health systems worldwide. Despite the potential benefits across diverse medical domains, a significant barrier to the successful adoption of AI systems in health care applications remains the prevailing low user trust in these technologies. Crucially, this challenge is exacerbated by the lack of consensus among experts from different disciplines on the definition of trust in AI within the health care sector. Objective: We aimed to provide the first consensus-based analysis of trust in AI in health care based on an interdisciplinary panel of experts from different domains. Our findings can be used to address the problem of defining trust in AI in health care applications, fostering the discussion of concrete real-world health care scenarios in which humans interact with AI systems explicitly. Methods: We used a combination of framework analysis and a 3-step consensus process involving 18 international experts from the fields of computer science, medicine, philosophy of technology, ethics, and social sciences. Our process consisted of a synchronous phase during an expert workshop where we discussed the notion of trust in AI in health care applications, defined an initial framework of important elements of trust to guide our analysis, and agreed on 5 case studies. This was followed by a 2-step iterative, asynchronous process in which the authors further developed, discussed, and refined notions of trust with respect to these specific cases. Results: Our consensus process identified key contextual factors of trust, namely, an AI system’s environment, the actors involved, and framing factors, and analyzed causes and effects of trust in AI in health care. Our findings revealed that certain factors were applicable across all discussed cases yet also pointed to the need for a fine-grained, multidisciplinary analysis bridging human-centered and technology-centered approaches. While regulatory boundaries and technological design features are critical to successful AI implementation in health care, ultimately, communication and positive lived experiences with AI systems will be at the forefront of user trust. Our expert consensus allowed us to formulate concrete recommendations for future research on trust in AI in health care applications. Conclusions: This paper advocates for a more refined and nuanced conceptual understanding of trust in the context of AI in health care. By synthesizing insights into commonalities and differences among specific case studies, this paper establishes a foundational basis for future debates and discussions on trusting AI in health care.
- Open Access
- 12 January 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Finding Consensus on Trust in AI in Health Care: Recommendations From a Panel of International Experts (Preprint)
BACKGROUND The integration of artificial intelligence (AI) into health care has become a crucial element in the digital transformation of health systems worldwide. Despite the potential benefits across diverse medical domains, a significant barrier to the successful adoption of AI systems in health care applications remains the prevailing low user trust in these technologies. Crucially, this challenge is exacerbated by the lack of consensus among experts from different disciplines on the definition of trust in AI within the health care sector. OBJECTIVE We aimed to provide the first consensus-based analysis of trust in AI in health care based on an interdisciplinary panel of experts from different domains. Our findings can be used to address the problem of defining trust in AI in health care applications, fostering the discussion of concrete real-world health care scenarios in which humans interact with AI systems explicitly. METHODS We used a combination of framework analysis and a 3-step consensus process involving 18 international experts from the fields of computer science, medicine, philosophy of technology, ethics, and social sciences. Our process consisted of a synchronous phase during an expert workshop where we discussed the notion of trust in AI in health care applications, defined an initial framework of important elements of trust to guide our analysis, and agreed on 5 case studies. This was followed by a 2-step iterative, asynchronous process in which the authors further developed, discussed, and refined notions of trust with respect to these specific cases. RESULTS Our consensus process identified key contextual factors of trust, namely, an AI system’s environment, the actors involved, and framing factors, and analyzed causes and effects of trust in AI in health care. Our findings revealed that certain factors were applicable across all discussed cases yet also pointed to the need for a fine-grained, multidisciplinary analysis bridging human-centered and technology-centered approaches. While regulatory boundaries and technological design features are critical to successful AI implementation in health care, ultimately, communication and positive lived experiences with AI systems will be at the forefront of user trust. Our expert consensus allowed us to formulate concrete recommendations for future research on trust in AI in health care applications. CONCLUSIONS This paper advocates for a more refined and nuanced conceptual understanding of trust in the context of AI in health care. By synthesizing insights into commonalities and differences among specific case studies, this paper establishes a foundational basis for future debates and discussions on trusting AI in health care.
- 12 January 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFinding Consensus on Trust in AI in Health Care: Recommendations From a Panel of International Experts (Preprint)
BACKGROUND The integration of artificial intelligence (AI) into health care has become a crucial element in the digital transformation of health systems worldwide. Despite the potential benefits across diverse medical domains, a significant barrier to the successful adoption of AI systems in health care applications remains the prevailing low user trust in these technologies. Crucially, this challenge is exacerbated by the lack of consensus among experts from different disciplines on the definition of trust in AI within the health care sector. OBJECTIVE We aimed to provide the first consensus-based analysis of trust in AI in health care based on an interdisciplinary panel of experts from different domains. Our findings can be used to address the problem of defining trust in AI in health care applications, fostering the discussion of concrete real-world health care scenarios in which humans interact with AI systems explicitly. METHODS We used a combination of framework analysis and a 3-step consensus process involving 18 international experts from the fields of computer science, medicine, philosophy of technology, ethics, and social sciences. Our process consisted of a synchronous phase during an expert workshop where we discussed the notion of trust in AI in health care applications, defined an initial framework of important elements of trust to guide our analysis, and agreed on 5 case studies. This was followed by a 2-step iterative, asynchronous process in which the authors further developed, discussed, and refined notions of trust with respect to these specific cases. RESULTS Our consensus process identified key contextual factors of trust, namely, an AI system’s environment, the actors involved, and framing factors, and analyzed causes and effects of trust in AI in health care. Our findings revealed that certain factors were applicable across all discussed cases yet also pointed to the need for a fine-grained, multidisciplinary analysis bridging human-centered and technology-centered approaches. While regulatory boundaries and technological design features are critical to successful AI implementation in health care, ultimately, communication and positive lived experiences with AI systems will be at the forefront of user trust. Our expert consensus allowed us to formulate concrete recommendations for future research on trust in AI in health care applications. CONCLUSIONS This paper advocates for a more refined and nuanced conceptual understanding of trust in the context of AI in health care. By synthesizing insights into commonalities and differences among specific case studies, this paper establishes a foundational basis for future debates and discussions on trusting AI in health care.
- Open Access
- 31 January 2022
- Published by Cambridge University Press (CUP)
- p. 21-42
‘Doing’ Medical Law and Ethics
Law and Legacy in Medical Jurisprudence - January 2022
- 31 January 2022
- Published by Cambridge University Press (CUP)
- p. 21-42
Open Access‘Doing’ Medical Law and Ethics
Law and Legacy in Medical Jurisprudence - January 2022
- Open Access
- 28 September 2020
- Published by Springer Nature in Neuroethics
- Vol. 14 (2) , 231-251
Narrative Devices: Neurotechnologies, Information, and Self-Constitution
This article provides a conceptual and normative framework through which we may understand the potentially ethically significant roles that information generated by neurotechnologies about our brains and minds may play in our construction of our identities. Neuroethics debates currently focus disproportionately on the ways that third parties may (ab)use these kinds of information. These debates occlude interests we may have in whether and how we ourselves encounter information about our own brains and minds. This gap is not yet adequately addressed by most allusions in the literature to potential identity impacts. These lack the requisite conceptual or normative foundations to explain why we should be concerned about such effects or how they might be addressed. This article seeks to fill this gap by presenting a normative account of identity as constituted by embodied self-narratives. It proposes that information generated by neurotechnologies can play significant content-supplying and interpretive roles in our construction of our self-narratives. It argues, to the extent that these roles support and detract from the coherence and inhabitability of these narratives, access to information about our brains and minds engages non-trivial identity-related interests. These claims are illustrated using examples drawn from empirical literature reporting reactions to information generated by implantable predictive BCIs and psychiatric neuroimaging. The article concludes by highlighting ways in which information generated by neurotechnologies might be governed so as to protect information subjects’ interests in developing and inhabiting their own identities.
- 28 September 2020
- Published by Springer Nature in Neuroethics
- Vol. 14 (2) , 231-251
Open AccessNarrative Devices: Neurotechnologies, Information, and Self-Constitution
This article provides a conceptual and normative framework through which we may understand the potentially ethically significant roles that information generated by neurotechnologies about our brains and minds may play in our construction of our identities. Neuroethics debates currently focus disproportionately on the ways that third parties may (ab)use these kinds of information. These debates occlude interests we may have in whether and how we ourselves encounter information about our own brains and minds. This gap is not yet adequately addressed by most allusions in the literature to potential identity impacts. These lack the requisite conceptual or normative foundations to explain why we should be concerned about such effects or how they might be addressed. This article seeks to fill this gap by presenting a normative account of identity as constituted by embodied self-narratives. It proposes that information generated by neurotechnologies can play significant content-supplying and interpretive roles in our construction of our self-narratives. It argues, to the extent that these roles support and detract from the coherence and inhabitability of these narratives, access to information about our brains and minds engages non-trivial identity-related interests. These claims are illustrated using examples drawn from empirical literature reporting reactions to information generated by implantable predictive BCIs and psychiatric neuroimaging. The article concludes by highlighting ways in which information generated by neurotechnologies might be governed so as to protect information subjects’ interests in developing and inhabiting their own identities.
- Open Access
- 31 August 2019
- Published by Springer Nature in Health Care Analysis
- Vol. 28 (2) , 99-120
Co-production and Managing Uncertainty in Health Research Regulation: A Delphi Study
European and international regulation of human health research is typified by a morass of interconnecting laws, diverse and divergent ethical frameworks, and national and transnational standards. There is also a tendency for legislators to regulate in silos—that is, in discrete fields of scientific activity without due regard to the need to make new knowledge as generalisable as possible. There are myriad challenges for the stakeholders—researchers and regulators alike—who attempt to navigate these landscapes. This Delphi study was undertaken in order to provide the first interdisciplinary and crosscutting analysis of health research regulation, as it is experienced by such stakeholders in the UK context. As well as reinforcing existing understandings of the regulatory environment, Delphi participants called for greater collaboration, and even co-production, of processes involved in health research regulation. On the basis of this research, we offer insights about how health research regulation can become a matter with which a wider range of stakeholders—including researchers, regulators, publics and research sponsors—can engage. The evidence supports the normative claim that health research regulation should continue to move away from strict, prescriptive rules-based approaches, and towards flexible principle-based regimes that allow researchers, regulators and publics to co-produce regulatory systems serving core principles. By unpacking thorny concepts and practices at the heart of health research regulation—including the public interest and public engagement—our results have the potential to situate and breathe life into them. The results also demonstrate that while proportionality is well-recognised as a crucial element of flexible regulatory systems, more must be done to operationalise this as an ethical assessment of the values and risks at stake at multiple junctures in the research trajectory. This is required if we are to move beyond proportionality as a mere risk-management tool. Compliance culture no longer accurately reflects the needs and expectations of researchers or regulators, nor does it necessarily produce the best research. Embracing uncertainty—both as a human practice and a regulatory objective—may represent the brighter future for health research.
- 31 August 2019
- Published by Springer Nature in Health Care Analysis
- Vol. 28 (2) , 99-120
Open AccessCo-production and Managing Uncertainty in Health Research Regulation: A Delphi Study
European and international regulation of human health research is typified by a morass of interconnecting laws, diverse and divergent ethical frameworks, and national and transnational standards. There is also a tendency for legislators to regulate in silos—that is, in discrete fields of scientific activity without due regard to the need to make new knowledge as generalisable as possible. There are myriad challenges for the stakeholders—researchers and regulators alike—who attempt to navigate these landscapes. This Delphi study was undertaken in order to provide the first interdisciplinary and crosscutting analysis of health research regulation, as it is experienced by such stakeholders in the UK context. As well as reinforcing existing understandings of the regulatory environment, Delphi participants called for greater collaboration, and even co-production, of processes involved in health research regulation. On the basis of this research, we offer insights about how health research regulation can become a matter with which a wider range of stakeholders—including researchers, regulators, publics and research sponsors—can engage. The evidence supports the normative claim that health research regulation should continue to move away from strict, prescriptive rules-based approaches, and towards flexible principle-based regimes that allow researchers, regulators and publics to co-produce regulatory systems serving core principles. By unpacking thorny concepts and practices at the heart of health research regulation—including the public interest and public engagement—our results have the potential to situate and breathe life into them. The results also demonstrate that while proportionality is well-recognised as a crucial element of flexible regulatory systems, more must be done to operationalise this as an ethical assessment of the values and risks at stake at multiple junctures in the research trajectory. This is required if we are to move beyond proportionality as a mere risk-management tool. Compliance culture no longer accurately reflects the needs and expectations of researchers or regulators, nor does it necessarily produce the best research. Embracing uncertainty—both as a human practice and a regulatory objective—may represent the brighter future for health research.
- 31 March 2014
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 21 (2) , 225-232
Book review: Governing Biobanks: Understanding the Interplay between Law and Practice, written by Jane Kaye, Susan M C Gibbons, Catherine Heeney, Michael Parker and Andrew Smart
"Book review: Governing Biobanks: Understanding the Interplay between Law and Practice, written by Jane Kaye, Susan M C Gibbons, Catherine Heeney, Michael Parker and Andrew Smart" published on 31 Mar 2014 by Brill | Nijhoff.
- 31 March 2014
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 21 (2) , 225-232
Book review: Governing Biobanks: Understanding the Interplay between Law and Practice, written by Jane Kaye, Susan M C Gibbons, Catherine Heeney, Michael Parker and Andrew Smart
"Book review: Governing Biobanks: Understanding the Interplay between Law and Practice, written by Jane Kaye, Susan M C Gibbons, Catherine Heeney, Michael Parker and Andrew Smart" published on 31 Mar 2014 by Brill | Nijhoff.